ACON

NASD Aclarion, Inc.

Nov 6, 2026 · 2:12 AM ET EOD Market Closed

$1.56 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.56, $0.18 below the day’s high of $1.74

YTD change: -66.09%
vs 20-day SMA: -21.14%
vs 200-day SMA: -44.73%

Price ranges

Previous day

$1.72 $1.79

open $1.79 close $1.74

-$0.05 (-2.79%)

Today

$1.54 $1.74

open $1.73 now $1.56

-$0.17 (-9.83%)

Past week

$1.71 $2.04

from $2.04 now $1.56

-$0.48 (-23.53%)

Past month

$1.71 $2.41

from $2.35 now $1.56

-$0.79 (-33.62%)

This year

$1.54 $9.36

from $4.60 now $1.56

-$3.04 (-66.09%)

Price & Performance

-1.64 (-51.25%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor

The stock is 100.0% away from all-time highs of $66,918.50
ACON is down 66% since the beginning of the year
ACON is down 79% over the past 12 months
ACON is down 34% over the past 1 month
1% of all ACON investors are betting against ACON

ACON reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -79.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-1.12

Earnings momentum +2.6% Quarterly EPS growth

Quarterly change +2.6%

Valuation

P/E ratio N/A

Enterprise value $-12026100.0

Beta 1.39

Balance sheet & scale

IncomeN/A

Revenue$83.8K

Cash$16.3M

DebtN/A

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Professional, Scientific, and Technical Services

Industry Group Scientific Research and Development Services

Market cap $4.5M

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.

Competitor comparison

Ticker	Company	Price	Change
AMGN	Amgen Inc.	$460.28	-3.80%
MRNA	Moderna, Inc.	$241.46	-6.55%
RVMD	Revolution Medicines, Inc.	$177.65	-11.04%
ROIV	Roivant Sciences Ltd.	$36.62	-4.21%
BNTX	BioNTech SE Sponsored ADR	$85.86	-5.34%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.